Novel pendrin inhibitor attenuates airway hyperresponsiveness and mucin expression in experimental murine asthma

J Allergy Clin Immunol. 2019 Nov;144(5):1425-1428.e12. doi: 10.1016/j.jaci.2019.07.016. Epub 2019 Jul 27.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Asthma / drug therapy*
  • Disease Models, Animal
  • Dual Oxidases / genetics
  • Dual Oxidases / metabolism
  • Eosinophils / immunology*
  • Gene Expression Regulation
  • Goblet Cells / pathology
  • Humans
  • Hyperplasia
  • Mice
  • Mucin 5AC / genetics
  • Mucin 5AC / metabolism
  • Mucins / genetics
  • Mucins / metabolism*
  • NIH 3T3 Cells
  • Nasal Mucosa / drug effects
  • Nasal Mucosa / physiology*
  • Neutrophils / immunology*
  • Oxazoles / chemistry
  • Oxazoles / therapeutic use*
  • Respiratory Hypersensitivity / drug therapy*
  • Sulfate Transporters / antagonists & inhibitors

Substances

  • Muc5ac protein, mouse
  • Mucin 5AC
  • Mucins
  • Oxazoles
  • Slc26a4 protein, mouse
  • Sulfate Transporters
  • YS-01
  • Dual Oxidases
  • Duox1 protein, mouse